NCT06798545

Brief Summary

The complexity of the medical expertise required for endoscopic manipulation and image interpretation complicates the implementation of echo-endoscopy (or EUS for "Endoscopic Ultrasound"). The "EZ-EUS" system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure. In this study, the intended purpose of the "EZ-EUS" system is to help echo-endoscopy operators to easily identify and assess the pancreatic gland, and to facilitate the detection of any lesions. The hypothesis is that, thanks to this tool, procedure times will be shortened, and the pancreas and its lesions will be fully imaged to facilitate their localization and characterization.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

January 28, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

January 21, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

endoscopic ultrasoundEUSnavigationpancreatic diseasetrainingeducationlearning curve

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the EUS navigation system's procedure duration compared to standard procedure times

    Comparison of the examination period duration between the two groups (experimental vs control)

    1 day

Secondary Outcomes (6)

  • Assessment of the EUS navigation system for patient safety

    1 month

  • Assessment of the system's ease-of-use and technological maturity

    1 day

  • Assessment of the EUS navigation system for reliability

    1 day

  • Evaluation of the time required to perform individual step duration

    1 day

  • Recording of procedure data for offline systeme performance assessment

    1 day

  • +1 more secondary outcomes

Study Arms (2)

EUS with EZ-EUS navigation system

EXPERIMENTAL

EUS with the experimental navigation system

Device: endoscopic ultrasound with navigation system

Standard EUS

NO INTERVENTION

EUS in standard condition

Interventions

Use of the EZ-EUS navigation system during the procedure

EUS with EZ-EUS navigation system

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Man or woman over the age of 18 years old.
  • Patient having a EUS procedure for pancreas study planned within the frame of his or her clinical care.
  • Patient whom pre-operative imaging indicates one lesion, a suspicion of lesion, chronic pancreatitis or fatty pancreas.
  • Patient with a good definition on the CT scan done within the year to the EUS.
  • Patient able to receive and understand information related to the study and give his or her written consent.
  • Patient affiliated to the French social security system.

You may not qualify if:

  • Patient with altered anatomy of the upper digestive tract due to previous surgery.
  • Patient with known abnormal anatomy of the upper digestive tract.
  • Patient wearing a pacemaker.
  • Patients with comorbidities that may increase the risk of perforation.
  • Patient presenting, according to the investigator's judgment, a disease which may prevent participation in the procedures provided for by the study.
  • Patient with an ASA \>3. Patient with ASA=3 must be validated by the Principal
  • Investigator (PI).
  • Patient unable to tolerate general anesthesia.
  • Patient with a body mass index (BMI) \< 18,5 and \> 40.
  • Patient with weight variations \>10% between the date on which the CT scan was performed and the date of the procedure.
  • Pregnant or lactating patient.
  • Patient under guardianship or trusteeship.
  • Patient under the protection of justice of deprives of liberty.
  • Patient in situation of emergency
  • Patient in need of the balloon during the navigation will be excluded of the study (Experimental group)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpitaux Universitaires de Strasbourg

Strasbourg, 67000, France

RECRUITING

MeSH Terms

Conditions

Pancreatic Diseases

Interventions

Endosonography

Condition Hierarchy (Ancestors)

Digestive System Diseases

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Leonardo SOSA-VALENCIA, MD

    IHU Strasbourg, HUS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2025

First Posted

January 29, 2025

Study Start

January 28, 2025

Primary Completion

January 1, 2026

Study Completion

March 1, 2026

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations